Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

NT-proBNP May Hold the Key to Predicting Cardiac Risk Before Noncardiac Surgery

Yael L. Maxwell

December 24, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Daily News

AHA/ACC Aim to Enhance Care of High BP With New Measures

Todd Neale

November 14, 2019

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

Obesity Prevalence Triples in China Over 10-Year Span

Michael O'Riordan

October 28, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Todd Neale

September 09, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

Advertisement

NT-proBNP May Hold the Key to Predicting Cardiac Risk Before Noncardiac Surgery

ISCHEMIA Questions? Some Answers From David Maron

AHA/ACC Aim to Enhance Care of High BP With New Measures

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Obesity Prevalence Triples in China Over 10-Year Span

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content